0001767877-20-000002.txt : 20200106
0001767877-20-000002.hdr.sgml : 20200106
20200106162914
ACCESSION NUMBER: 0001767877-20-000002
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200102
FILED AS OF DATE: 20200106
DATE AS OF CHANGE: 20200106
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Foster Aaron E.
CENTRAL INDEX KEY: 0001767877
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36783
FILM NUMBER: 20510103
MAIL ADDRESS:
STREET 1: C/O BELLICUM PHARMACEUTICALS, INC.
STREET 2: 2130 W. HOLCOMBE BLVD., STE 800
CITY: HOUSTON
STATE: TX
ZIP: 77030
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BELLICUM PHARMACEUTICALS, INC
CENTRAL INDEX KEY: 0001358403
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 201450200
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2130 WEST HOLCOMBE BOULEVARD
STREET 2: SUITE 800
CITY: HOUSTON
STATE: TX
ZIP: 77030
BUSINESS PHONE: (832) 384-1100
MAIL ADDRESS:
STREET 1: 2130 WEST HOLCOMBE BOULEVARD
STREET 2: SUITE 800
CITY: HOUSTON
STATE: TX
ZIP: 77030
FORMER COMPANY:
FORMER CONFORMED NAME: BELLICUM PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20060405
4
1
wf-form4_157834613724866.xml
FORM 4
X0306
4
2020-01-02
0
0001358403
BELLICUM PHARMACEUTICALS, INC
BLCM
0001767877
Foster Aaron E.
C/O BELLICUM PHARMACEUTICALS, INC.
2130 W. HOLCOMBE BLVD., STE. 800
HOUSTON
TX
77030
0
1
0
0
Sr VP, Head of Research
Common Stock
2020-01-02
4
M
0
2500
A
7834
D
Common Stock
2020-01-02
4
F
0
942
1.51
D
6892
D
Common Stock
2020-01-03
4
M
0
625
A
7517
D
Common Stock
2020-01-03
4
F
0
236
1.40
D
7281
D
Restricted Stock Units
2020-01-02
4
M
0
2500
0
D
Common Stock
2500.0
5000
D
Restricted Stock Units
2020-01-03
4
M
0
625
0
D
Common Stock
625.0
625
D
Each Restricted Stock Unit (the "RSU") represents a contingent right to receive one share of BLCM common stock.
Includes 1,597 shares acquired by the reporting person under the Issuer's Employee Stock Purchase Plan.
Represents the number of shares withheld by and surrendered to the Issuer on January 2, 2020, to satisfy tax withholding obligations that arose in connection with the vesting of the RSUs granted to the reporting person on January 2, 2018 for 10,000 shares.
Represents the number of shares withheld by and surrendered to the Issuer on January 3, 2020, to satisfy tax withholding obligations that arose in connection with the vesting of the RSUs granted to the reporting person on January 3, 2017 for 2,500 shares.
On January 2, 2018, the reporting person was granted 10,000 RSUs, of which 2,500 vested on January 2, 2020. The RSUs vest in four annual installments beginning on January 2, 2019.
On January 3, 2017, the reporting person was granted 2,500 RSUs, of which 625 vested on January 3, 2020. The RSUs vest in four annual installments beginning on January 3, 2018.
/s/ Aaron E. Foster
2020-01-06